Zepbound vs Wegovy trial and compounded GLP-1s

Docs Who Lift - En podcast af Docs Who Lift

Prøv Podimo gratis! i 30 dage

Et univers fyldt med hundredvis af eksklusive podcasts & lydbøger, klik her for at prøve

Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.

Visit the podcast's native language site